
Sign up to save your podcasts
Or


Many pharmaceutical companies are getting out of Alzheimer's research because they aren't finding that "silver bullet" treatment to cure the disease. However, perhaps we should instead be looking for the "silver buckshot" treatment, because it is only by addressing many smaller areas of concern that you effectively reduce your risk for Alzheimer's Disease. In the second episode of a series with Dr. David Perlmutter, Dr. Daniel Amen and Tana Amen discuss some of these "silver buckshot" elements, such as exercise and monitoring your glycemic load.
By Dr Daniel & Tana Amen4.7
19361,936 ratings
Many pharmaceutical companies are getting out of Alzheimer's research because they aren't finding that "silver bullet" treatment to cure the disease. However, perhaps we should instead be looking for the "silver buckshot" treatment, because it is only by addressing many smaller areas of concern that you effectively reduce your risk for Alzheimer's Disease. In the second episode of a series with Dr. David Perlmutter, Dr. Daniel Amen and Tana Amen discuss some of these "silver buckshot" elements, such as exercise and monitoring your glycemic load.

7,265 Listeners

1,085 Listeners

21,174 Listeners

1,706 Listeners

4,884 Listeners

3,503 Listeners

9,198 Listeners

27,343 Listeners

49 Listeners

1,340 Listeners

1,458 Listeners

19,492 Listeners

1,196 Listeners

1,360 Listeners

3,156 Listeners